QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NASDAQ:SMTI

Sanara MedTech - SMTI Stock Forecast, Price & News

$39.96
+0.21 (+0.53%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$39.00
$40.73
50-Day Range
$39.75
$48.74
52-Week Range
$17.41
$49.50
Volume
29,971 shs
Average Volume
12,379 shs
Market Capitalization
$331.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00

Sanara MedTech MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
25.1% Upside
$50.00 Price Target
Short Interest
Bearish
2.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.55mentions of Sanara MedTech in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.27) to $0.28 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

Medical Sector

716th out of 983 stocks

Surgical Appliances & Supplies Industry

17th out of 23 stocks


SMTI stock logo

About Sanara MedTech (NASDAQ:SMTI) Stock

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Receive SMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

SMTI Stock News Headlines

27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Analyzing Sanara MedTech (NASDAQ:SMTI) & STERIS (NYSE:STE)
Earnings Outlook For Sanara MedTech
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Sanara MedTech Inc. Announces Third Quarter 2022 Results
Sanara MedTech Inc. (SMTI)
See More Headlines
Receive SMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

SMTI Company Calendar

Last Earnings
3/20/2023
Today
3/21/2023
Next Earnings (Estimated)
5/15/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMTI
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+24.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,920,000.00
Pretax Margin
-35.15%

Debt

Sales & Book Value

Annual Sales
$24.14 million
Book Value
$3.95 per share

Miscellaneous

Free Float
3,454,000
Market Cap
$332.83 million
Optionable
Not Optionable
Beta
1.88

Key Executives

  • Zach Fleming
    Chief Executive Officer
  • Michael D. McNeil
    Secretary, Chief Financial & Accounting Officer
  • Rebecca E. Mcmahon
    President-Research & Development
  • Susan Dieter
    Clinical Director, Head-Wound Care & Surgical
  • Bill Fitzgerald
    Compliance Officer













SMTI Stock - Frequently Asked Questions

Should I buy or sell Sanara MedTech stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sanara MedTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SMTI shares.
View SMTI analyst ratings
or view top-rated stocks.

What is Sanara MedTech's stock price forecast for 2023?

1 Wall Street research analysts have issued twelve-month price targets for Sanara MedTech's shares. Their SMTI share price forecasts range from $50.00 to $50.00. On average, they expect the company's share price to reach $50.00 in the next twelve months. This suggests a possible upside of 24.7% from the stock's current price.
View analysts price targets for SMTI
or view top-rated stocks among Wall Street analysts.

How have SMTI shares performed in 2023?

Sanara MedTech's stock was trading at $45.50 on January 1st, 2023. Since then, SMTI shares have decreased by 11.9% and is now trading at $40.10.
View the best growth stocks for 2023 here
.

When is Sanara MedTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our SMTI earnings forecast
.

How were Sanara MedTech's earnings last quarter?

Sanara MedTech Inc. (NASDAQ:SMTI) posted its quarterly earnings results on Monday, March, 20th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.04. The firm had revenue of $15.32 million for the quarter. Sanara MedTech had a negative net margin of 30.33% and a negative trailing twelve-month return on equity of 32.84%. During the same period last year, the firm posted ($0.48) earnings per share.

What guidance has Sanara MedTech issued on next quarter's earnings?

Sanara MedTech updated its fourth quarter 2022 earnings guidance on Wednesday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $15.30 million-$15.30 million, compared to the consensus revenue estimate of $14.80 million.

What other stocks do shareholders of Sanara MedTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC).

What is Sanara MedTech's stock symbol?

Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI."

Who are Sanara MedTech's major shareholders?

Sanara MedTech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.34%), Susquehanna International Group LLP (0.18%), Bamco Inc. NY (0.13%), Citigroup Inc. (0.11%), Millennium Management LLC (0.10%) and Price T Rowe Associates Inc. MD (0.07%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming.
View institutional ownership trends
.

How do I buy shares of Sanara MedTech?

Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sanara MedTech's stock price today?

One share of SMTI stock can currently be purchased for approximately $40.10.

How much money does Sanara MedTech make?

Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $332.83 million and generates $24.14 million in revenue each year. The company earns $-7,920,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis.

How can I contact Sanara MedTech?

Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com.

This page (NASDAQ:SMTI) was last updated on 3/21/2023 by MarketBeat.com Staff